Clinical Trials
97
Trial Phases
4 Phases
Drug Approvals
43
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
Distribution across different clinical trial phases (62 trials with phase data)• Click on a phase to view related trials
News
STAMPEDE Trial Shows Metformin Improves Metabolic Health in Metastatic Prostate Cancer Patients Despite No Survival Benefit
The STAMPEDE trial found that adding metformin to standard care for 1,874 non-diabetic men with metastatic prostate cancer did not significantly improve overall survival (HR 0.91, 95% CI: 0.80-1.03, P = 0.15).
Protein Therapeutics Market Surges to $400 Billion as 20 New Drugs Gain Approval in 2023
The global protein therapeutics market reached an estimated $400 billion in value, driven by increasing pharmaceutical company investment in advanced protein-based drug development strategies.
Tevogen Bio Expands TVGN 489 Pipeline to Include Patients 65 and Older, Targeting $1 Billion Launch Year Revenue
Tevogen Bio announced plans to expand TVGN 489's target population to include patients aged 65 and older, building on previous specialty care pipeline projections of nearly $1 billion in launch year revenue.
Federal Circuit Rules Against Teva's Orange Book Patent Listings for ProAir HFA Inhaler
The U.S. District Court ordered Teva Pharmaceuticals to remove its ProAir HFA inhaler device patents from the FDA's Orange Book, ruling they don't meet statutory listing requirements.
FDA Approves First Rapid-Acting Insulin Biosimilar Merilog for Diabetes Management
The FDA has granted approval to insulin-aspart-szjj (Merilog), marking the first rapid-acting insulin biosimilar for diabetes treatment, expanding treatment options for over 38 million Americans with diabetes.
MRD Negativity Emerges as Key Endpoint in Multiple Myeloma Trials
Minimal Residual Disease (MRD) testing offers a sensitive method for detecting remaining cancer cells, influencing treatment decisions and improving patient outcomes in multiple myeloma.